Chandra D. Lovejoy is VP of Regulatory Affairs at ENDOCYTE INC (ECYT). They have made 3 open-market trades across 2 companies since 2012, most recently 2016-01-12.
CIK 0001290149
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNAI | SELL | 2016-01-12 | 2016-01-14 | $11.29 | $474K | -11.9% | -37.7% | -37.7% |
| DNAI | SELL | 2016-01-12 | 2016-01-14 | $11.29 | $237K | -11.9% | -37.7% | -37.7% |
| ECYT | SELL · 10b5-1 | 2014-08-11 | 2014-08-13 | $7.00 | $150K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL | 2013-08-06 | 2013-08-08 | $17.29 | $121K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-02-25 | 2013-02-26 | $9.70 | $20K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-01-25 | 2013-01-29 | $9.56 | $21K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-12-26 | 2012-12-28 | $9.05 | $20K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-11-26 | 2012-11-27 | $8.72 | $19K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-10-25 | 2012-10-29 | $9.71 | $21K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-09-25 | 2012-09-27 | $10.28 | $23K | -24.6% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.